Drug giant AstraZeneca (AZN) has bought Boston-based Modella AI to speed up its cancer research work.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The aim is to integrate Modella’s AI agents into AZN’s oncology research and development. AZN’s shares were lower in mid-trading.